机构:[1]Department of Cardiology, Center for Coronary Heart Disease, Fu Wai Hospital, National Center forCardiovascular Diseases of China, State Key Laboratory of Cardiovascular Disease, Chinese Academy of MedicalSciences and Peking Union Medical College, Beijing, China[2]Department of Cardiology, Anqing Hospital affiliatedto Anhui Medical University, Anqing City, Anhui Province, China[3]Department of Cardiovascular Medicine,Guangdong Provincial Key Laboratory of Biomedical Imaging, Fifth Affiliated Hospital of Sun Yat-sen University,Zhuhai City, Guangdong Province, China[4]Department of Cardiology, Beijing Anzhen Hospital, Capital MedicalUniversity, Beijing, China首都医科大学附属安贞医院[5]Department of Cardiology, Institute of Cardiovascular Disease, Yichang Central People’sHospital, China Three Gorges University, Yichang City, Hubei Province, China[6]Department of Cardiology, DayeChinese Medicine Hospital, Daye City, Hubei Province, China[7]Department of Cardiology ,the First AffiliatedHospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei City,Anhui Province, China[8]Department of Infectious Diseases ,the First Affiliated Hospital of USTC, Division of LifeSciences and Medicine, University of Science and Technology of China, Hefei City, Anhui Province, China[9]Coronary Care Unit, Baoding No. 1 Central Hospital, Baoding City, Hebei Province, China[10]Sixth Department ofHepatopathy, Baoding People’s Hospital, Baoding City, Hebei Province, China[11]Department of Gastroenterology,Yingcheng Chinese Medicine Hospital, Yingcheng City, Hubei Province, China[12]Department of Otolaryngology,Daye People’s Hospital, Daye City, Hubei Province, China[13]Medical Research & Biometrics Center ,Fu WaiHospital, National Center for Cardiovascular Diseases of China, State Key Laboratory of Cardiovascular Disease,Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China[14]Division ofCardiology, Department of Internal Medicine, The Center for Cardiovascular Biology and Atherosclerosis Research,McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas, USA
Hypertension represents one of the most common pre-existing conditions and comorbidities in Coronavirus disease 2019 (COVID-19) patients. To explore whether hypertension serves as a risk factor for disease severity, a multi-centre, retrospective study was conducted in COVID-19 patients. A total of 498 consecutively hospitalised patients with lab-confirmed COVID-19 in China were enrolled in this cohort. Using logistic regression, we assessed the association between hypertension and the likelihood of severe illness with adjustment for confounders. We observed that more than 16% of the enrolled patients exhibited pre-existing hypertension on admission. More severe COVID-19 cases occurred in individuals with hypertension than those without hypertension (21% vs. 10%, P = 0.007). Hypertension associated with the increased risk of severe illness, which was not modified by other demographic factors, such as age, sex, hospital geological location and blood pressure levels on admission. More attention and treatment should be offered to patients with underlying hypertension, who usually are older, have more comorbidities and more susceptible to cardiac complications.
基金:
National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81670337]; Foundation for clinical and translational medical research, Central Public Welfare Research of Chinese Academy of Medical Sciences [2019xk320061]; Talent cultivation program of Beijing Municipal Bureau of Medical Administration [QML20150602]
第一作者机构:[1]Department of Cardiology, Center for Coronary Heart Disease, Fu Wai Hospital, National Center forCardiovascular Diseases of China, State Key Laboratory of Cardiovascular Disease, Chinese Academy of MedicalSciences and Peking Union Medical College, Beijing, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Zhi-Yao Wei,Rui Qiao,Jian Chen,et al.The influence of pre-existing hypertension on coronavirus disease 2019 patients[J].EPIDEMIOLOGY AND INFECTION.2021,149:doi:10.1017/S0950268820003118.
APA:
Zhi-Yao Wei,Rui Qiao,Jian Chen,Ji Huang,Hui Wu...&Yong-Jian Geng.(2021).The influence of pre-existing hypertension on coronavirus disease 2019 patients.EPIDEMIOLOGY AND INFECTION,149,
MLA:
Zhi-Yao Wei,et al."The influence of pre-existing hypertension on coronavirus disease 2019 patients".EPIDEMIOLOGY AND INFECTION 149.(2021)